KENLIFABI
Pharmaceutical preparations for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, for the treatment of glycolipid storage disorders, and for the treatment of cancer
Pending · August 27, 2025 · 99360014 ·